Evidence map›Paper›PMID 30196238›Full record

ArticleTranslational oncology2018

Survival Impact of Delaying Postoperative Radiotherapy in Patients with Esophageal Cancer.

Yuanyuan Wang, Shanghui Guan, Yanhong Bi, Sixiang Lin, Jianjun Ma, Qian Xing, Chonghua Liu, Rui Zhang, Zhen Qu, Peng Jiang and 2 more

Abstract read
In one paragraph

Article in Translational oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yuanyuan WangDepartment of Oncology, Linyi People's Hospital, Shandong, China.
Shanghui GuanDepartment of Radiation Oncology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Yanhong BiDepartment of Oncology, The Second People's Hospital of Dezhou, Shandong, China.
Sixiang LinCancer Treatment Center, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, Shandong, China.
Jianjun MaDepartment of Cancer Treatment, The 107th Hospital of the People's Liberation Army, Yantai, Shandong, China.
Qian XingDepartment of Oncology, Linyi People's Hospital, Shandong, China.
Chonghua LiuDepartment of Oncology, Linyi People's Hospital, Shandong, China.
Rui ZhangDepartment of Oncology, Linyi People's Hospital, Shandong, China.
Zhen QuDepartment of Cancer Treatment, The 107th Hospital of the People's Liberation Army, Yantai, Shandong, China.
Peng JiangDepartment of Cancer Treatment, The 107th Hospital of the People's Liberation Army, Yantai, Shandong, China.
Xue ChenDepartment of Radiation Oncology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Yufeng ChengDepartment of Radiation Oncology, Qilu Hospital of Shandong University, Jinan, Shandong, China. Electronic address: chengyuan201711@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of the current study was to retrospectively assess the effect of postoperative radiotherapy (RT) delay on survival for patients with esophageal cancer. From 2008 to 2011, patients with esophageal cancer who had undergone postoperative RT in five different hospitals in China were reviewed. Clinical data, including time interval between surgery to RT, were prospectively collected. Kaplan-Meier method was conducted to estimate the effect of each variable on progression-free survival (PFS) and overall survival (OS), with differences assessed by log-rank test. Univariate Cox proportional-hazards models were performed for both PFS and OS for all assumed predictor variables. Statistically significant predictor variables (P < .05) on univariate analysis were then included in multivariate Cox proportional-hazards models, which were performed to compare the effects of RT delay on PFS and OS. A total of 316 patients were finally enrolled in this prospectively multicentric study. Time to RT after surgery varied from 12 days to over 60 days (median, 26 days). Multivariate analysis showed that delay to RT longer than the median does not appear to be a survival cost. There was also no statistically difference in PFS (P = .513) or OS (P = .236) between patients stratified by quartiles (≤21 days vs ≧35 days). However, patients with particularly long delays (≧42 days) demonstrated a detrimental impact on OS (P = .021) but not PFS (P = .580). Delaying postoperative RT of esophageal cancer does not impact PFS, but results in a significant reduction on OS if delaying longer than 6 weeks.

Identifiers

PMID30196238
PMCPMC6132173

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.